- Country: Chile
- Summary: "Cetuximab Y Panitumumab"
- CLT Ref No: 82260642
- Deadline: 08 May 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 5051-42-LQ23
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Name of the tender : "Cetuximab Y Panitumumab"
Description : The objective of this tender is the acquisition of CETUXIMAB AND PANITUMUMAB for the Regional Hospital of Talca, in order to ensure quality and timely supply, to satisfy the demand for the users for u1edf014045db26d31a02a5bbb8891997n period of 24 months.
Type of bidding:Publica-Public Bidding equal to or greater than 2,000 UTM and less than 5,000 UTM (LQ)
Cirre closes:08-05-2023 16:30:00 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN"Cetuximab Y Panitumumab" - Chile Tender
The HEALTH SERVICE OF THE MAULE HOSPITAL OF TALCA, a Government sector organization in Chile, has announced a new tender for "Cetuximab Y Panitumumab". This tender is published on ChileTenders under CLT Ref No: 82260642 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-05-08.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
